Dr Ian Flinn at ASH 2014: Preliminary results of a phase Ib study combining ABT-199 and obinutuzumab in CLL - 101271

Spotlight
Video

Dr Ian Flinn at ASH 2014: Preliminary results of a phase Ib study combining ABT-199 and obinutuzumab in CLL

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Ian Flinn (Sarah Cannon Cancer Institute, Nashville, TN) discusses the preliminary results of a phase Ib study (GP28331) combining GDC-0199 (ABT-199) and obinutuzumab in patients with relapsed/refractory or previously untreated chronic lymphocytic leukaemia (CLL).
Shared By : EMJ
Posted on : 01/27/15
Added : 3 years ago